Skip to content
We've opened a community investment round!
Join Founders Fund, Lux Capital, and Innovation Endeavors as an investor.
Invest now
Home
Our Science
Therapeutic Areas
Team & Investors
Careers
News & Resources
Invest
News
& Resources
Featured Stories
Globe NewsWire
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Read More
Siren Biotechnology Opens Community Investment Round!
Read More
Press Release
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
Read More
News
Patient Resources
Videos
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 12.5.22
Insights from Nicole Paulk on the latest gene therapy for hemophilia B
Read More
Media Coverage
|
Posted on 8.25.22
Siren’s Founder & CEO, Nicole Paulk, speaks on pricing and access for gene therapies
Read More
Media Coverage
|
Posted on 10.1.21
Hear from Nicole Paulk on XLMTM gene therapy
Read More
Media Coverage
|
Posted on 8.12.21
Nicole Paulk on gene therapy’s next steps
Read More
Media Coverage
|
Posted on 5.17.21
Beyond AAV 1.0 – Nicole Paulk discusses breaking down barriers for the future of AAV
Read More
1
…
3
4
5
